BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15564725)

  • 1. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
    Jelinek DF; Darce JR
    Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uncertain glory of APRIL.
    Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
    Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
    Shivakumar L; Ansell S
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BLyS and B cell homeostasis.
    Woodland RT; Schmidt MR; Thompson CB
    Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BAFF/APRIL system: life beyond B lymphocytes.
    Ng LG; Mackay CR; Mackay F
    Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and accumulation of B cells in TACI-deficient mice.
    Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
    Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of proteoglycans as the APRIL-specific binding partners.
    Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
    J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemistry and biology of BAFF, APRIL and their receptors.
    Kalled SL; Ambrose C; Hsu YM
    Curr Dir Autoimmun; 2005; 8():206-42. PubMed ID: 15564723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
    Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
    Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel function of TNF cytokines in regulating bone marrow B cell survival.
    Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
    Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF, APRIL and human B cell disorders.
    Tangye SG; Bryant VL; Cuss AK; Good KL
    Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
    Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
    Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of APRIL and BAFF in lymphocyte activation.
    Schneider P
    Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils.
    Scapini P; Bazzoni F; Cassatella MA
    Immunol Lett; 2008 Feb; 116(1):1-6. PubMed ID: 18155301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To B or not to B: TNF family signaling in lymphocytes.
    Siegel RM; Lenardo MJ
    Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
    Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
    Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists.
    Stohl W
    Curr Dir Autoimmun; 2005; 8():289-304. PubMed ID: 15564726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.